$XELB
XCel Brands, Inc.

2017 Q1 Form 10-Q Financial Statement

#000114420417026495 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $8.430M $8.361M
YoY Change 0.83% 26.85%
Cost Of Revenue $0.00 $70.00K
YoY Change -100.0% 55.56%
Gross Profit $8.430M $8.322M
YoY Change 1.3% 27.13%
Gross Profit Margin 100.0% 99.53%
Selling, General & Admin $7.600M $7.560M
YoY Change 0.53% 40.26%
% of Gross Profit 90.15% 90.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $394.0K $426.0K
YoY Change -7.51% 62.6%
% of Gross Profit 4.67% 5.12%
Operating Expenses $7.995M $7.980M
YoY Change 0.19% 41.49%
Operating Profit $435.0K $339.0K
YoY Change 28.32% 18.12%
Interest Expense -$380.0K -$440.0K
YoY Change -13.64% -13.73%
% of Operating Profit -87.36% -129.79%
Other Income/Expense, Net
YoY Change
Pretax Income $57.00K -$96.00K
YoY Change -159.38% -57.14%
Income Tax $456.0K -$51.00K
% Of Pretax Income 800.0%
Net Earnings -$399.0K -$45.00K
YoY Change 786.67% -86.4%
Net Earnings / Revenue -4.73% -0.54%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02 -$2.709K
COMMON SHARES
Basic Shares Outstanding 18.67M shares 18.46M shares
Diluted Shares Outstanding 18.67M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.20M $12.60M
YoY Change -19.05% 103.23%
Cash & Equivalents $10.20M $12.59M
Short-Term Investments
Other Short-Term Assets $900.0K $700.0K
YoY Change 28.57% -61.11%
Inventory
Prepaid Expenses
Receivables $8.700M $9.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.80M $22.40M
YoY Change -11.61% 74.35%
LONG-TERM ASSETS
Property, Plant & Equipment $2.600M $973.0K
YoY Change 167.21% 16.67%
Goodwill $12.37M
YoY Change 0.0%
Intangibles $112.0M
YoY Change 14.87%
Long-Term Investments
YoY Change
Other Assets $3.000M $287.0K
YoY Change 945.3% 4.74%
Total Long-Term Assets $129.0M $126.8M
YoY Change 1.72% 13.63%
TOTAL ASSETS
Total Short-Term Assets $19.80M $22.40M
Total Long-Term Assets $129.0M $126.8M
Total Assets $148.8M $149.2M
YoY Change -0.28% 19.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $2.300M
YoY Change -4.35% -20.69%
Accrued Expenses $800.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.200M $7.864M
YoY Change -21.16% 18.88%
Total Short-Term Liabilities $9.300M $10.17M
YoY Change -8.53% -40.74%
LONG-TERM LIABILITIES
Long-Term Debt $23.80M $30.79M
YoY Change -22.71% -14.57%
Other Long-Term Liabilities $2.200M $600.0K
YoY Change 266.67% 200.0%
Total Long-Term Liabilities $26.00M $38.09M
YoY Change -31.73% -13.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.300M $10.17M
Total Long-Term Liabilities $26.00M $38.09M
Total Liabilities $42.70M $48.25M
YoY Change -11.51% -21.06%
SHAREHOLDERS EQUITY
Retained Earnings $6.021M
YoY Change 90.48%
Common Stock $94.95M
YoY Change 57.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $106.1M $101.0M
YoY Change
Total Liabilities & Shareholders Equity $148.8M $149.2M
YoY Change -0.28% 19.9%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$399.0K -$45.00K
YoY Change 786.67% -86.4%
Depreciation, Depletion And Amortization $394.0K $426.0K
YoY Change -7.51% 62.6%
Cash From Operating Activities -$1.012M -$1.302M
YoY Change -22.27% 225.5%
INVESTING ACTIVITIES
Capital Expenditures $135.0K $246.0K
YoY Change -45.12% 811.11%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$153.0K -$246.0K
YoY Change -37.8% 500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $795.0K $282.0K
YoY Change 181.91%
Debt Paid & Issued, Net $1.959M $2.125M
YoY Change -7.81% 112.5%
Cash From Financing Activities -$2.761M -2.730M
YoY Change 1.14% 45.21%
NET CHANGE
Cash From Operating Activities -$1.012M -$1.302M
Cash From Investing Activities -$153.0K -$246.0K
Cash From Financing Activities -$2.761M -2.730M
Net Change In Cash -$3.926M -$1.548M
YoY Change 153.62% 251.02%
FREE CASH FLOW
Cash From Operating Activities -$1.012M -$1.302M
Capital Expenditures $135.0K $246.0K
Free Cash Flow -$1.147M -$1.548M
YoY Change -25.9% 262.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
871000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1083000 USD
CY2016Q1 us-gaap Salaries And Wages
SalariesAndWages
4210000 USD
CY2017Q1 us-gaap Salaries And Wages
SalariesAndWages
4367000 USD
CY2016Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1345000 USD
CY2017Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1280000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
426000 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
394000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
7995000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
435000 USD
CY2017Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
328000 USD
CY2017Q1 us-gaap Other Financial Services Costs
OtherFinancialServicesCosts
50000 USD
CY2017Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
378000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
456000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-399000 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
394000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000 USD
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
50000 USD
CY2016Q1 xelb Amortization Of Seller Note Discount
AmortizationOfSellerNoteDiscount
80000 USD
CY2017Q1 xelb Amortization Of Seller Note Discount
AmortizationOfSellerNoteDiscount
9000 USD
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-51000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
456000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1534000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1737000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-557000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-159000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
297000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
21000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
66000 USD
CY2017Q1 xelb Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisesInPeriod
0 shares
CY2017Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
83000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-153000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-246000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
795000 USD
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
302000 USD
CY2017Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7000 USD
CY2016Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
69000 USD
CY2017Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1959000 USD
CY2016Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2125000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3926000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4274000 USD
CY2016Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1110000 USD
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-647000 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
112000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
110000 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
270000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
370000 USD
CY2017Q1 xelb Payment Of Earnout Obligations
PaymentOfEarnoutObligations
0 USD
CY2016Q1 xelb Payment Of Earnout Obligations
PaymentOfEarnoutObligations
-250000 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18000 USD
CY2016Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12586000 USD
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1109000 USD
CY2017Q1 xelb Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11710000 USD
CY2016Q1 xelb Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13695000 USD
CY2016Q4 xelb Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15636000 USD
CY2015Q4 xelb Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17969000 USD
CY2017Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
114909000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3954000 USD
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
114891000 USD
CY2017Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
472000 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
509000 USD
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
30010000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
31922000 USD
CY2017Q1 xelb Long Term Debt And Contingent Obligations Current
LongTermDebtAndContingentObligationsCurrent
6193000 USD
CY2016Q4 xelb Long Term Debt And Contingent Obligations Current
LongTermDebtAndContingentObligationsCurrent
6427000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2436000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3229000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
811670 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.98
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.66
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.8
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.66
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.01
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M17D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M10D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M4D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
XCel Brands, Inc.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001083220
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
XELB
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18447692 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18447692 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18447692 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18644982 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18644982 shares
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-96000 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18674943 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18458748 shares
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
8430000 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
8361000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1012000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1302000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2761000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2726000 USD
CY2016Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
-70000 USD
CY2017Q1 us-gaap Royalty Expense
RoyaltyExpense
9000 USD
CY2016Q1 us-gaap Royalty Expense
RoyaltyExpense
34000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
50000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25000 shares
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
283000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
282000 USD
CY2017Q1 xelb Minimum Liquidity Covenants
MinimumLiquidityCovenants
3000000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
the Company shall pay an early termination fee equal to the principal amount outstanding under the Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date.
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18458748 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3380 pure
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3520 pure
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0155 pure
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0202 pure
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
8 pure
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.53 pure
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
7.37 pure
CY2017Q1 xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.29 pure
CY2016Q1 xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.19 pure

Files In Submission

Name View Source Status
0001144204-17-026495-index-headers.html Edgar Link pending
0001144204-17-026495-index.html Edgar Link pending
0001144204-17-026495.txt Edgar Link pending
0001144204-17-026495-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465962_10q.htm Edgar Link pending
v465962_ex31-1.htm Edgar Link pending
v465962_ex31-2.htm Edgar Link pending
v465962_ex32-1.htm Edgar Link pending
v465962_ex32-2.htm Edgar Link pending
xelb-20170331.xml Edgar Link completed
xelb-20170331.xsd Edgar Link pending
xelb-20170331_cal.xml Edgar Link unprocessable
xelb-20170331_def.xml Edgar Link unprocessable
xelb-20170331_lab.xml Edgar Link unprocessable
xelb-20170331_pre.xml Edgar Link unprocessable